Twenty Japanese companies exhibited welfare equipment related to elderly care and healthcare at CIFTIS in Beijing. Takeda Pharmaceutical Company Limited also participated for the first time, highlighting opportunities to bring technologies and products developed to address Japan’s aging population to the Chinese market.
The Japan External Trade Organization (JETRO) coordinated the participation of 20 Japanese companies at CIFTIS, a trade fair for services held from the 9th to the 13th at Beijing Shougang Park in Beijing, China. Elderly care equipment and health-related products for older people were showcased, providing an opportunity to explore new avenues for cooperation in services trade between Japan and China.
Sagisaka Hirotaka (匂坂拓孝), director of JETRO’s Beijing Office, attended the exhibition in support of the Japanese companies and said that new opportunities are emerging in services trade between Japan and China. While interest in improving quality of life for older people is growing in China, Japan aims to leverage its accumulated expertise in elderly care and welfare services, as well as products and health-related technologies for older people, to develop offerings suited to the Chinese market.
Takeda China, the Chinese subsidiary of Takeda Pharmaceutical Company Limited, exhibited at CIFTIS for the first time, showcasing its initiatives in healthcare and the latest developments in its development pipeline. The company highlighted practical applications in the Chinese market and the expansion of global collaboration, expressing its desire to deepen cooperation by leveraging opportunities arising from China’s opening-up policy.
CIFTIS is regarded as an important venue for Japanese companies to expand their points of contact with the Chinese market, contributing to stronger cooperation between Japan and China and a better understanding of market trends. Experiences from companies that have exhibited in the past indicate that the fair is an effective venue for gaining insight into the latest developments in the Chinese market and building future business partnerships.